Photodynamic Therapy (PDT)

PDT combines the application of a photosensitizing topical medication, aminolevulinic acid HCl (ALA), with a particular wave length of light (BLU-light) activation. This treatment is FDA approved for the treatment of a type of precancerous Lesions called Actinic keratoses (AKs). AKs commonly develop on sun exposed areas, such as the face and scalp. Because AKs commonly progress into non-melanoma types of skin cancers, PDT has become a first line treatment to avoid deforming invasive surgeries. PDT-ALA is also prescribed for treating sebaceous gland enlargement as commonly occurs in Rosacea and moderate to severe acne.

Our experienced staff will apply the medication, following a thorough microdermabrasion of the treatment area, to enhance ALA penetration. Patients will need to spend a prescribed period of time in our waiting room allowing the targeted abnormal epidermal cells to metabolize the ALA into photosensitive molecules. Activation with the BLU-light safely destroys the target cells. Post-treatment requires 48 hours of complete sunblock/solar avoidance, so schedule your PDT treatment with plans to remain indoors afterward.



3 Namskaket Rd.
Orleans, MA 02653
fax 888-448-6765


View Email Address *

* Your privacy is our utmost concern. Even though our company uses a secure, encrypted email service, your email account most likely does not. Your electronic communication has a possibility to be intercepted and read by a third party. Don't email information such as your birthday, social security number, or any private medical information. We will not diagnose your condition via email. Communication via email cannot replace the professional relationship we will foster in person. Many Thanks!